Advertisement
Research Article
Long-term sucrose solution consumption causes metabolic alterations and affects hepatic oxidative stress in Wistar rats
Ellen Mayara Souza Cruz, Juliana Maria Bitencourt de Morais, Carlos Vinícius Dalto da Rosa, Mellina da Silva Simões, Jurandir Fernando Comar, Luiz Gustavo de Almeida Chuffa, Fábio Rodrigues Ferreira Seiva
Biology Open 2020 9: bio047282 doi: 10.1242/bio.047282 Published 28 February 2020

ABSTRACT

As the number of overweight and obese people has risen in recent years, there has been a parallel increase in the number of people with metabolic syndrome, diabetes and non-alcoholic fatty liver disease. The consumption of artificially sweetened beverages contributes to these epidemics. This study investigated the long-term effects of ingestion of a 40% sucrose solution on serum and hepatic parameters in male Wistar rats (Rattus norvegicus). After 180 days, the glycemic response, lipid profile and hepatic oxidative stress were compared to those of rats maintained on water. Sucrose ingestion led to higher body weight, increased fat deposits, reduced voluntary food intake and reduced feeding efficiency. Rats that received sucrose solution showed early signs of glucose intolerance and insulin resistance, such as hyperinsulinemia. Serum triacylglycerol (TG), very-low density lipoprotein (VLDL), cholesterol, ALT and AST levels increased after sucrose consumption. Elevated malondialdehyde and superoxide dismutase (SOD) levels and reduced glutathione levels characterize the hepatic oxidative stress due to sucrose ingestion. Liver sample histology showed vacuolar traces and increased fibrotic tissue. Our data showed the harmful effects of chronic consumption of sucrose solution, which can cause alterations that are found frequently in obesity, glucose intolerance and non-alcoholic hepatic disease, characteristics of metabolic syndrome.

INTRODUCTION

During the past few decades, a dramatic rise in the overweight and obese population has become a global epidemic (Engin, 2017). Generally, an excess of energy intake over energy expenditure leads to obesity development, but genetics, medical conditions and lifestyle are factors that should not be ruled out (Skolnik and Ryan, 2014). Obesity can aggravate: (1) insulin resistance (IR); (2) diabetes mellitus type 2 (DM2); (3) dyslipidemia; and (4) accumulation of visceral fat. When these factors are combined, they characterize metabolic syndrome (MS), which in turn is associated with non-alcoholic fatty liver disease (NAFLD) (Caixas et al., 2014; Simopoulos, 2013).

Consumption of high-calorie, processed foods predisposes an individual to metabolic syndrome and hepatic disorders (Lustig et al., 2012; Stenvinkel, 2015). The consumption of artificially-sweetened beverages is also increasing in parallel with the prevalence of obesity and type 2 diabetes (Aydin et al., 2014; Malik et al., 2010). Sucrose (a disaccharide composed of glucose and fructose), or high-fructose corn syrup, containing about 50% to 55% fructose, are commonly added to artificially-sweetened beverages (Jensen et al., 2018). An important point that deserves attention is that liquid and solid meals differ in terms of energy gained, appetite and food intake responses (DiMeglio and Mattes, 2000; Pan and Hu, 2011; Stull et al., 2008). Many studies designed to evaluate the effects of sucrose and fructose use hypercaloric diets supplemented with lipids, carbohydrates, or both, in solid meals of animals from different species or strains (Abe et al., 2019; Devan et al., 2018; Jimoh et al., 2018; Lima et al., 2016; Sousa et al., 2018; Sun et al., 2018; Xu et al., 2019; Zhang et al., 2016). Few studies have investigated the effects of long-term (>3 months) consumption of sucrose solution versus drinking water in Wistar rats (Rattus norvegicus) (Aguilera et al., 2004; Chen et al., 2011; El Hafidi et al., 2001; Kawasaki et al., 2005; Masek et al., 2017). Some of these studies showed higher glycaemia and body weight caused by sucrose consumption, but others did not; furthermore, among these studies only Aguilera et al. (2004) evaluated lipid serum parameters, so more research might contribute to the understanding of the effects of liquid sucrose consumption.

Postprandial glucose disposal depends on normal liver function, and the composition of ingested carbohydrates influences hepatic glucose metabolism. Rats fed 10% sucrose solution developed hepatic steatosis and had impaired hepatic free radical defenses (Armutcu et al., 2005). Sucrose consumption causes fat accumulation in the liver, and subsequent development of hepatic insulin resistance, an independent risk factor for NAFLD (DiNicolantonio et al., 2015). The hyperinsulinemia due to insulin resistance increases precursors for hepatic fibrosis, reduces β-oxidation of fatty acids, and increases the generation of free radicals (Li et al., 2017; Paradis et al., 2001; Sun et al., 2018). The harmful effects of sugar-enriched diets and the association between sugar and NAFLD were comprehensively reviewed by Wong et al. (2016) and Jensen et al. (2018), respectively.

Because the effects of consuming sucrose solution are still being debated, and because the liver plays a pivotal role in glucose and lipid metabolism, we investigated the effects of long-term liquid sucrose consumption on nutritional, morphometric, serum biochemical markers and hepatic oxidative stress parameters, which may draw attention to the effects of excessive consumption of artificially sweetened beverages.

RESULTS

Initial body weight was not statistically different between groups and was similar until the seventh week (Fig. 1). Animals in both groups had a higher final body weight compared to their initial body weight (P<0.001). After 180 days, the animals receiving sucrose solution had a higher final body weight than control animals (P=0.01). Food consumption (P<0.001), voluntary food intake (P<0.001) and feed efficiency (P<0.01) were lower in the sucrose group but liquid consumption (P<0.01), and energy intake (P<0.001) were higher. BMI, Lee index and abdominal circumference were similar, but the sucrose group had longer body length than the control group (P<0.01) (Table 1).

Fig. 1.
Fig. 1.

Body-weight gain of rats receiving filtered water (Control) and Sucrose solution. Data were expressed as mean±SE (n=6 in each group), and analyzed by Student's t-test; P≤5%.

View this table:
Table 1.

Morphometric and nutritional parameters of rats receiving filtered water (Control) and Sucrose solution.

During oral glucose tolerance tests (OGTT), basal glucose levels were higher in the sucrose group (P<0.001) (Fig. 2A). After glucose injection, glycemia remained elevated at 90 min (P=0.018) and 120 min (P<0.001). The insulin tolerance test (ITT) results showed elevated basal glucose levels in sucrose-fed animals (P<0.001). In both groups, there was a reduction in glycemia in response to insulin injection; however, animals that consumed sucrose solution showed a delayed decrease in glucose concentrations (Fig. 2B). After 30 min, the glucose levels remained high in the sucrose group (P<0.001) (Fig. 2B). The area under the curve (AUC) – both OGTT-AUC and ITT-AUC – were elevated in the sucrose group (P<0.001) (Fig. 2C). The sucrose group had elevated fasting insulin (P=0.018), Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) (P<0.001) and TyG index (P<0.001) values, and markedly reduced quantitative insulin check index (QUICKI) (P=0.002) and hepatic insulin sensitivity (HIS) (P=0.003) indices (Table 2).

Fig. 2.
Fig. 2.

(A) Oral glucose tolerance test; (B) insulin tolerance test; (C) AUC results of rats receiving filtered water (Control) and Sucrose solution. Data expressed as mean±SE (n=6 in each group), and analyzed by paired t-test; P≤5%.

View this table:
Table 2.

Insulin sensitivity indices of rats receiving filtered water (Control) and Sucrose solution

Sucrose consumption caused considerable increased visceral (P<0.001), retroperitoneal (P<0.001), epididymal (P=0.02) fat depots and adiposity index (P<0.001) (Fig. 3A,B). The basal lipolysis rate in the control and sucrose groups were not statistically different (Fig. 3C).

Fig. 3.
Fig. 3.

(A) Fat depots, (B) adiposity index, (C) lipolysis basal rate of rats receiving filtered water (Control) and Sucrose solution. Data were expressed as mean±SE (n=6 in each group), and analyzed by Student's t-test; P≤5%.

Sucrose solution consumption markedly increased serum TG (P<0.001), cholesterol (P<0.01) and VLDL (P<0.001) levels (Fig. 4A), thus supporting the dyslipidemia. The cardiovascular indices were higher in the sucrose group, TG/HDL (P<0.001) and TC/HDL (P<0.01) (Fig. 4B,C).

Fig. 4.
Fig. 4.

(A) Serum lipid profile, (B) cholesterol/HDL ratio, (C) TG/HDL ratio of rats receiving filtered water (Control) and Sucrose solution. Data were expressed as mean±SE (n=6 in each group), and analyzed by Student's t-test; P≤5%.

Sucrose ingestion elevated the alanine transaminase (ALT) (P<0.01) and aspartate transaminase (AST) (P<0.001) levels significantly. TG levels were higher in the livers of animals from the sucrose group (P=0.04), but cholesterol and glycogen levels were not statistically different (Table 3). The oxidative stress (OS) marker, Malondialdehyde (MDA), was elevated in rats consuming sucrose solution and these animals showed reduction of reduced glutathione (GSH), oxidized glutathione (GSSG), GSH+2× GSSG ratio (P<0.001 for all the referred parameters) and SOD activity (P<0.01) (Table 3).

View this table:
Table 3.

Hepatic parameters of rats receiving filtered water (Control) and Sucrose solution

Although not statistically different, the hepatocyte numbers were lower, while the hepatocyte size was increased in the sucrose group (Table 4). The sucrose group also showed higher hepatocyte ballooning and vacuolization within hepatocytes (Fig. 5B) compared to the control group (Fig. 5A). The collagen content in the hepatic parenchyma was significantly higher in the sucrose group and more concentrated in the perisinusoidal and pericentral regions (Fig. 5D).

View this table:
Table 4.

Histological features of liver of rats receiving filtered water (Control) and Sucrose solution

Fig. 5.
Fig. 5.

Photomicrograph of section of H&E stained liver of rats receiving filtered water (Control) (A) and Sucrose solution (B). Picrosirius Red stained section of liver of rats receiving filtered water (Control) (C) and Sucrose solution (D). The red stain in C and D indicates collagen. Black arrows indicate hepatocyte vacuolation, white arrows indicate hepatocyte ballooning.

DISCUSSION

Metabolic syndrome accompanied by insulin resistance, impaired glucose tolerance and dyslipidemia are closely associated with obesity, which in turn is related to excess dietary energy intake. Both metabolic syndrome and obesity are also related to hepatic disorders, including NAFLD (Rahman et al., 2017). In this study we confirmed the obesogenic effect of liquid sucrose consumption during a relative short period, i.e. after 8 weeks of disaccharide consumption, and the results are similar to those caused by high-fat diet consumption (Jimoh et al., 2018). The increased final body weight in the sucrose group was associated with increased fat depots and increased adiposity index. The animals consuming sucrose showed decreased food consumption and voluntary food intake, due to the high energy content of sucrose solution. Furthermore, sucrose ingestion diminished feed efficiency, suggesting that sucrose metabolism alters processes involved in the regulation of body weight and exhibits adverse nutritional effects. Morphometric parameters were not influenced by sucrose ingestion, similar to what was reported by Malafaia et al. (2013).

6 months after receiving the sucrose solution, rats exhibited similar glycemia. Rodrigues et al. (2016) showed no changes in glucose levels in rats fed with enriched fructose diet. Furthermore, normal fasting blood glucose levels were observed in subjects with diabetes (Bartoli et al., 2011). Other studies using sucrose-supplemented diet showed elevation (Chen et al., 2011), maintenance (Dutta et al., 2001) or reduction of glycemia (Del Toro-Equihua et al., 2016). Rats have stable energy metabolism, thus showing resistance to the development of full metabolic syndrome features with sucrose supplementation alone (Sun et al., 2018). In short, conflicting results are reported when fasting glucose alone is considered (Campbell et al., 2017). Hence, we conducted OGTT and ITT for an accurate assessment of the effects of sucrose solution consumption. Our results showed impaired glucose utilization in animals receiving sucrose, an early hallmark of type 2 diabetes mellitus, and obesity. The higher area under the curve corroborates these results and reflects those of Rahman et al. (2017), who demonstrated that high energy intake led to glucose intolerance. However, there is an important difference; animals from the Rahman et al. (2017) study were fed a high-carbohydrate and high-fat solid diet. Therefore, we emphasize that excessive consumption of sucrose-enriched beverages is as harmful as excessive high-carbohydrate and high-fat solid diet ingestion, considering the availability of glucose. Although the animals are euglycemic, glucose intolerance and insulin resistance are confirmed (Table 2). Liquid sucrose ingestion causes hyperinsulinemia and alters insulin sensitivity indices. Altogether, these data support the presence of insulin resistance due to sucrose solution consumption. These findings suggest that sucrose ingestion alters both pancreatic insulin secretion and peripheral tissues’ insulin sensitivity.

The hormone insulin is necessary for fat metabolism and both lipogenesis and lipolysis are critical pathways involved in balancing adipose tissue lipid content. The sucrose group showed marked elevation of fat deposition and adiposity index, supporting the earlier observations by Malafaia et al. (2013). Increased levels of glucose and fructose serve as acetyl-CoA sources for conversion to fatty acids for storage in hepatic and adipose tissues, thus contributing to NAFLD and obesity, respectively (Sanders and Griffin, 2016). Increased fat depots in the sucrose group could be due to higher caloric intake from the diet (Castro et al., 2017). Insulin resistance is known to increase adipose tissue lipolysis, although reduced fatty acid oxidation was documented in obesity and was associated with TG accumulation (Bouanane et al., 2010).

There are distinct causes of insulin resistance. For instance, GLUT4 is responsible for glucose transport in adipocytes, and altered expression might be related to intrinsic IR. Mice with GLUT4 deletion show insulin resistance, while GLUT4 overexpression improves glucose handling. In both cases, the fatty acid synthesis, termed de novo lipogenesis (DNL) is under the regulation of carbohydrate response element binding protein (ChREBP) (Vijayakumar et al., 2017) and sterol regulatory element binding protein 1C (SREBP1c) (Alves-Bezerra and Cohen, 2017) such that DNL is regulated primarily at the transcriptional level. Both transcriptional factors are activated by increased insulin signaling and increased glucose concentrations, which could partly explain our results. Further investigations are ongoing to test this hypothesis.

Dyslipidemia is a common feature in subjects with MS or DM2, thus reinforcing the close relationship between MS or DM2 and NAFLD (Sanders and Griffin, 2016). In hepatocytes, fructose, in contrast to glucose, undergoes alternative metabolism involving a highly specific enzyme, fructokinase (E.C. 2.7.1.4). This alternative step bypasses the PFK-1 regulatory role, to produce triose phosphates for DNL and interferes with the hepatic insulin signaling (Lim et al., 2010). In our experiment, the blood collection was from animals in a fasted state, and so the sole source for TG was the liver. Sucrose solution consumption induces hepatic TG synthesis, which explains the higher VLDL concentrations. Decreased endothelial cell lipoprotein lipase activity was associated with low TG clearance in fructose-fed rats (Nakagawa et al., 2006). The dyslipidemic profile seen in our rats was also shown by Oliveira Crege et al. (2016) and Wan et al. (2017) in studies of rats that consumed high-fat, and high-fat, high-cholesterol diets, respectively. The hypercholesterolemia and hypertriglyceridemia in the sucrose group indicated that sucrose solution consumption influences cardiovascular risk factors as well; such alterations may be associated with the fructose component of the solution. Nakagawa et al. (2006) showed that fructose, but not glucose, is related to MS. In brief, dyslipidemia caused by sucrose consumption is associated with increased risk for hepatic and cardiac disorders, and altered insulin-mediated metabolic responses; features consistent with MS.

The increased ALT and AST levels after sucrose consumption, indicate hepatocyte injury, thus corroborating data from rats fed solid sucrose-enriched diet (Xu et al., 2019). In the skeletal muscle of animals and humans, TG accumulation is an important contributor to muscle IR (Pan et al., 1997). This ectopic accumulation of lipids affects the liver, and contributes to NAFLD (Monteillet et al., 2018). We speculate an association of higher hepatic TG with reduced HIS, contributing to hyperinsulinemia in our rats. The higher content of fat depots impairs the peripheral insulin action (Oliveira Crege et al., 2016). Interestingly, some studies have discussed the accumulation of liver TG as a potential protective mechanism (Tilg and Moschen, 2010; Unger and Scherer, 2010).

Animals from the sucrose group displayed evidences of hepatic metabolic imbalance, such as reduced glutathione and SOD (Table 3). Moreover, increased MDA and decreased GSH/GSSG and GSH+2x GSSG ratios are also indicative of hepatic metabolic dysfunction, culminating in OS, which could be due to impaired ROS scavenging system and ROS production (Sa-Nakanishi et al., 2018), thus suggesting that rat livers from the sucrose group failed to maintain the redox state. An association between carbohydrate consumption and OS is seen frequently in the literature (Ecker et al., 2017; Kosuru and Singh, 2017). Gregersen et al. (2012) showed reduced total antioxidant capacity in the blood shortly after a high carbohydrate meal. Similarly, our data show that even without fasting hyperglycemia, glucose intolerance, and IR interfere with hepatic oxidative parameters. However, it cannot be ruled out that a higher hepatic TG content may be associated with elevated OS in sucrose-fed rats.

Rats from the sucrose group showed morphological alterations in the hepatic parenchyma. Sugar ingestion initiates structural changes, such as a reduction in hepatocyte number and increased hepatocyte size, characteristics related to hepatocyte ballooning, a frequent feature of the damaged liver (Corona-Perez et al., 2017). We also observed higher vacuolation in the sucrose group, which is related to increased cellular deposits and cellular damage (Nayak et al., 1996). Moreover, we observed the presence of collagen in the liver of sucrose-fed animals, and the mild fibrosis occurred mainly in the perisinusoidal region and pericentral zone, relating to NAFLD (Kleiner et al., 2005). The higher levels of transaminases found in our study suggest disruption of the liver function (Kaswala et al., 2016). Corona-Perez et al. (2017) showed similar results with 8 weeks of sucrose supplementation, classifying their results as moderate grade fibrosis. In contrast, Masek et al. (2017) showed no evidence of liver fibrosis after 20 weeks of sucrose supplementation, despite higher lipid content.

Lastly, we discuss two limitations of this study: first, we did not investigate the molecular mechanisms underlying these alterations; second, since sucrose solution reduced food consumption by >50%, it could have resulted in nutritional imbalances in the animals. Future studies are required to address the above findings.

In conclusion, consumption of 40% sucrose solution for 180 days caused elevation of fat depots, altered glycemic and lipid profiles. Hepatic tissue showed elevated oxidative stress markers and morphological alterations, hallmarks of NAFLD. Altogether, sucrose-containing beverages could be obesogenic, and the physical form of the ingested carbohydrates is relevant for understanding the global health problems occurring over the past decades.

MATERIALS AND METHODS

Animals and experimental protocol

The experimental design and the analysis were conducted following the ethical principles for animal research established by the Brazilian Council for Control of Animal Experimentation, and approved by the Animal Ethics Committee of North of Parana State University, UENP, Brazil (protocol number: CEUA 05/2017).

Twelve male Wistar rats, 60 days old, were housed in an environmentally-controlled clean-air room, under standard temperature (22±3°C), 12 h light-and-dark cycles and relative humidity of 60±5%. The animals were randomly assigned into two groups (n=6). Both groups received standard chow (NuvilabCR1®, Nuvilab, Brazil) ad libitum. Controls (C), received filtered water, and the Sucrose (S) treatment rats received 40% sucrose solution prepared daily. This treatment continued for 180 days.

Nutritional and morphometric parameters

Every week body weight, food and liquid consumption were measured between 9–10 am, and the difference between the total and the leftover food and drinking solution calculated. Food and liquid intake, and caloric values of chow (3.09 kcal/g) (Lima et al., 2016) and sucrose solution (1.6 kcal/mL), were used to obtain the following parameters: total energy intake (EI, kcal/day), feed efficiency (FE, %) and, voluntary food intake (VFI, %) (Seiva et al., 2012). At the end of the experimental period, animals under anesthesia had their body weight (BW), and body length (BL) determined to calculate body mass index (BMI) and Lee index [cube root of body weight (g)/nose-to-anus length (cm)] (Chuffa and Seiva, 2013). Abdominal circumference was also measured.

Oral glucose and insulin tolerance tests

5 and 2 days before the end of the experiment, rats were submitted to oral glucose tolerance test (OGTT) and insulin tolerance test (ITT), respectively, and blood samples were collected for insulin quantification. For the OGTT, rats were deprived of food for 6 h, and were administered 2 g/kg body weight of glucose as a 20% aqueous solution via oral gavage. Blood samples were obtained from the tail vein before and at 15, 30, 60, 90 and 120 min after glucose administration. For the ITT, rats were injected intra-peritoneally with 1 U/kg of BW of regular human insulin (Humulin™ Eli Lilly, São Paulo, Brazil) and blood samples collected before and at 15, 30, 60 and 90 min after insulin administration. The trapezoidal rule was used to determine the AUC for OGTT and ITT (Antunes et al., 2016). Blood glucose levels were measured using an automated glucose analyzer (Accu-Chek Active, Roche®, SP, Brazil). Serum insulin quantification was performed using an enzyme-linked immunosorbent assay kit (Mouse Insulin ELISA kit, Thermo Fisher Scientific, USA). The insulin sensitivity indices, such as homeostasis model assessment of insulin resistance (HOMA IR=fasting insulin×fasting glucose/22.5) (Antunes et al., 2016); quantitative insulin sensitivity check index [QUICKI=1/(log insulin concentration+log blood glucose concentration)] (Bowe et al., 2014); the product of fasting plasma glucose and triglyceride [TyG index=ln (fasting triacylglycerol×fasting glucose/2)] (Lee et al., 2018); hepatic insulin sensitivity (HIS=1000/fasting insulin×fasting glucose) (Matsuda and DeFronzo, 1999) were calculated. HIS assumes that higher values of the product of glucose and insulin are inversely related to the capacity of the liver to respond to insulin.

Biological material collection

At the end of the experimental protocol, fasting rats were euthanized by barbiturate overdose (Zatroch et al., 2017). Blood samples were collected via cardiac puncture, placed into centrifuge tubes, allowed to clot and centrifuged at 5000 rpm for 10 min. Serum aliquots were frozen at −80°C for the following analyses: ALT, AST, TG, total cholesterol (TC), and high-density lipoprotein (HDL) were determined using commercial enzymatic methods (CELM diagnosis, São Paulo, Brazil). The concentration of VLDL and low-density lipoprotein was measured as described elsewhere (Pinafo et al., 2019). The values from the above determinations were used to calculate the cardiometabolic risk indices as follows, CR1=TC/HDL (Kosuru and Singh, 2017) and CR2=TG/HDL (Wang et al., 2017).

White adipose tissue depots, retroperitoneal, epididymal and visceral were dissected rapidly and weighed, and the data were used to calculate the adiposity index (%) (Seiva et al., 2011). Epididymal adipose tissue portions (50 mg) were collected and incubated for 1 h in an appropriate buffer at 37°C, and aliquots were heated to 70°C to inactivate enzyme. Glycerol levels were measured using a commercial kit, and the ratio of the concentration of glycerol and epididymal weight was determined as the basal lipolytic index (Rodrigues et al., 2016). The liver was dissected and weighed, and liver samples were stored at −80°C for the determination of hepatic oxidative stress and glycogen content. The left lobe of the liver was collected and used for histological preparations.

Hepatic parameters

For preparing the liver homogenate, the frozen tissue was homogenized in a Potter-Elvehjem homogenizer with 10-volumes of ice-cold 0.1 M potassium phosphate buffer (pH 7.4). The homogenate was centrifuged at 10,000 rpm for 15 min, and the supernatant used as the soluble fraction. Protein carbonyl groups were measured spectrophotometrically using 2,4-dinitrophenylhydrazine (Levine et al., 1990). The levels of protein carbonyl groups were calculated using the molar extinction coefficient (ε) of 2.20×104 M−1·cm−1. MDA was measured by the thiobarbituric acid-reactive substances assay (Buege, 1978). The levels of glutathione, reduced (GSH) and oxidized (GSSG) were measured with a spectrofluorimetric method (excitation at 350 nm and emission at 420 nm) using the o-phthalaldehyde assay as described earlier (Hissin and Hilf, 1976). The catalase activity using H2O2 as substrate was determined by measuring the change in absorbance at 240 nm (Aebi, 1974), and the results were calculated using the molar extinction coefficient (ε) of 9.6×10−3 M−1·cm−1. The activity of SOD was estimated by its capacity to inhibit pyrogallol autoxidation in the alkaline medium at 420 nm (Marklund and Marklund, 1974). One SOD unit is equal to the quantity of enzyme that causes 50% inhibition, and the results were expressed as units·mg protein−1.

Approximately 200 mg of hepatic tissue was homogenized with 0.01 M sodium phosphate buffer (pH 7.4), using an L-beader cell disrupter with 3 mm zirconium beads (3720 rpm, 2 min). Later, the homogenate was centrifuged at 10,000 rpm for 15 min at 4°C, and the supernatant collected for quantification of total glycogen content by the anthrone assay (Roe and Dailey, 1966).

Liver processing and histological analysis

After 24 h of fixation in Bouin's solution, the left lobe of the liver was processed for histology (dehydrated, diaphanized, and paraffin-embedded) and 5-µm thick semi-serial sections were obtained. These sections were stained with either Hematoxylin and Eosin (H&E) (for morphometric analysis of hepatocytes), or Picrosirius Red counter-stained with Hematoxylin (for collagen analysis).

The liver microphotographs were captured using a light microscope coupled to a high-resolution camera, with a 200× magnification in the area of the central vein. For the H&E stained slides, from each animal, 30 images were captured with an exact area of 0.216 mm2 each, excluding a fixed area around the central vein. The hepatocyte numbers in these images were counted, the cytoplasmic area of 100 hepatocytes/animal were measured, and the images analyzed using the program Image Pro Plus 4.5 software (Media Cybernetics, Maryland, USA).

We captured 30 images/animal with the Picrosirius Red-stained slides to evaluate the area marked for collagen. The area analyzed was the same from the H&E technique. The percentage area of collagen was obtained using the ImageJ FIJI software, based on the threshold from RGB stacks.

Statistical analysis

Statistical comparisons were performed using the Sigma Plot software (version 11.0). The results are presented as the mean±SEM and are discussed considering P<5%. The results were analyzed using Student's t-test. For OGTT and ITT tests, glycaemia was measured at different times after the oral load of glucose. Differences between control and sucrose groups, within fixed time, were analyzed by repeated samples (paired) t-test.

Footnotes

  • Competing interests

    The authors declare no competing or financial interests.

  • Author contributions

    Conceptualization: F.R.F.S.; Methodology: M.d.S.S., J.F.C., L.G.d.A.C.; Formal analysis: E.M.S.C., J.M.B.d.M., C.V.D.d.R., J.F.C.; Investigation: E.M.S.C., J.M.B.d.M., C.V.D.d.R.; Data curation: C.V.D.d.R., M.d.S.S., J.F.C.; Writing - original draft: L.G.d.A.C.; Supervision: F.R.F.S.; Project administration: F.R.F.S.

  • Funding

    This study was supported by the Brazilian agencies Conselho Nacional de Desenvolvimento Científico e Tecnológico and Fundação Araucária (number: 05/2018 – CIC/PROPG/UENP) in the form of undergraduate scholarship. Universidade Estadual do Norte do Paraná – UENP/PROPG/EDITORA UENP contributed paying the publication charge.

  • Received August 23, 2019.
  • Accepted February 6, 2020.
http://creativecommons.org/licenses/by/4.0

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

References

  1. ↵
    1. Abe, N.,
    2. Kato, S.,
    3. Tsuchida, T.,
    4. Sugimoto, K.,
    5. Saito, R.,
    6. Verschuren, L.,
    7. Kleemann, R. and
    8. Oka, K.
    (2019). Longitudinal characterization of diet-induced genetic murine models of non- alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients. Biol. Open 8, doi:10.1242/bio.041251
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Aebi, H.
    (1974). Catalase. In Methods of Enzymatic Analysis, vol. III (ed. H.-U. Bergmeyer). Elsevier Inc. 673-677
  3. ↵
    1. Aguilera, A. A.,
    2. Diaz, G. H.,
    3. Barcelata, M. L.,
    4. Guerrero, O. A. and
    5. Ros, R. M.
    (2004). Effects of fish oil on hypertension, plasma lipids, and tumor necrosis factor-alpha in rats with sucrose-induced metabolic syndrome. J. Nutr. Biochem. 15, 350-357, doi:10.1016/j.jnutbio.2003.12.008
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Alves-Bezerra, M. and
    2. Cohen, D. E.
    (2017). Triglyceride metabolism in the liver. Compr. Physiol. 8, 1-8, doi:10.1002/cphy.c170012
    OpenUrlCrossRef
  5. ↵
    1. Antunes, L. C.,
    2. Elkfury, J. L.,
    3. Jornada, M. N.,
    4. Foletto, K. C. and
    5. Bertoluci, M. C.
    (2016). Validation of HOMA-IR in a model of insulin-resistance induced by a high-fat diet in Wistar rats. Arch. Endocrinol. Metab. 60, 138-142, doi:10.1590/2359-3997000000169
    OpenUrlCrossRef
  6. ↵
    1. Armutcu, F.,
    2. Coskun, O.,
    3. Gurel, A.,
    4. Kanter, M.,
    5. Can, M.,
    6. Ucar, F. and
    7. Unalacak, M.
    (2005). Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats. Clin. Biochem. 38, 540-547, doi:10.1016/j.clinbiochem.2005.01.013
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    1. Aydin, S.,
    2. Aksoy, A.,
    3. Aydin, S.,
    4. Kalayci, M.,
    5. Yilmaz, M.,
    6. Kuloglu, T.,
    7. Citil, C. and
    8. Catak, Z.
    (2014). Today's and yesterday’ s of pathophysiology: biochemistry of metabolic syndrome and animal models. Nutrition 30, 1-9, doi:10.1016/j.nut.2013.05.013
    OpenUrlCrossRef
  8. ↵
    1. Bartoli, E.,
    2. Fra, G. P. and
    3. Schianca, G. P. C.
    (2011). The oral glucose tolerance test (OGTT) revisited. Eur. J. Intern. Med. 22, 8-12, doi:10.1016/j.ejim.2010.07.008
    OpenUrlCrossRefPubMed
  9. ↵
    1. Bouanane, S.,
    2. Merzouk, H.,
    3. Benkalfat, N. B.,
    4. Soulimane, N.,
    5. Merzouk, S. A.,
    6. Gresti, J.,
    7. Tessier, C. and
    8. Narce, M.
    (2010). Hepatic and very low-density lipoprotein fatty acids in obese offspring of overfed dams. Metabolism 59, 1701-1709, doi:10.1016/j.metabol.2010.04.003
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Bowe, J. E.,
    2. Franklin, Z. J.,
    3. Hauge-Evans, A. C.,
    4. King, A. J.,
    5. Persaud, S. J. and
    6. Jones, P. M.
    (2014). Metabolic phenotyping guidelines: assessing glucose homeostasis in rodent models. J. Endocrinol. 222, G13-G25, doi:10.1530/JOE-14-0182
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Buege, J. A. A. and
    2. Aust, S. D.
    (1978). Microsomal lipid peroxidation. Methods Enzymol. 52, 302-310. doi:10.1016/S0076-6879(78)52032-6
    OpenUrlCrossRefPubMed
  12. ↵
    1. Caixas, A.,
    2. Albert, L.,
    3. Capel, I. and
    4. Rigla, M.
    (2014). Naltrexone sustained release/bupropion sustained-release for the management of obesity: review of the data to date. Drug Des. Dev. Ther. 8, 1419-1427, doi:10.2147/DDDT.S55587
    OpenUrlCrossRef
  13. ↵
    1. Campbell, G. J.,
    2. Senior, A. M. and
    3. Bell-Anderson, K. S.
    (2017). Metabolic effects of high glycaemic index diets: a systematic review and meta-analysis of feeding studies in mice and rats. Nutrients 9, doi:10.3390/nu9070646
    OpenUrlCrossRef
  14. ↵
    1. Castro, C. A.,
    2. da Silva, K. A.,
    3. Buffo, M. M.,
    4. Pinto, K. N. Z.,
    5. Duarte, F. O.,
    6. Nonaka, K. O.,
    7. Anibal, F. F. and
    8. Duarte, A.
    (2017). Experimental type 2 diabetes induction reduces serum vaspin, but not serum omentin, in Wistar rats. Int. J. Exp. Pathol. 98, 26-33, doi:10.1111/iep.12220
    OpenUrlCrossRef
  15. ↵
    1. Chen, G. C.,
    2. Huang, C. Y.,
    3. Chang, M. Y.,
    4. Chen, C. H.,
    5. Chen, S. W.,
    6. Huang, C. J. and
    7. Chao, P. M.
    (2011). Two unhealthy dietary habits featuring a high fat content and a sucrose-containing beverage intake, alone or in combination, on inducing metabolic syndrome in Wistar rats and C57BL/6J mice. Metabolism 60, 155-164, doi:10.1016/j.metabol.2009.12.002
    OpenUrlCrossRefPubMed
  16. ↵
    1. Chuffa, L. G. and
    2. Seiva, F. R.
    (2013). Combined effects of age and diet-induced obesity on biochemical parameters and cardiac energy metabolism in rats. Indian J. Biochem. Biophys. 50, 40-47.
    OpenUrlPubMed
  17. ↵
    1. Corona-Perez, A.,
    2. Diaz-Munoz, M.,
    3. Cuevas-Romero, E.,
    4. Luna-Moreno, D.,
    5. Valente- Godinez, H.,
    6. Vazquez-Martinez, O.,
    7. Martinez-Gomez, M.,
    8. Rodriguez-Antolin, J. and
    9. Nicolas-Toledo, L.
    (2017). Interactive effects of chronic stress and a high-sucrose diet on nonalcoholic fatty liver in young adult male rats. Stress 20, 608-617, doi:10.1080/10253890.2017.1381840
    OpenUrlCrossRef
  18. ↵
    1. Del Toro-Equihua, M.,
    2. Velasco-Rodriguez, R.,
    3. Lopez-Ascencio, R. and
    4. Vasquez, C.
    (2016). Effect of an avocado oil-enhanced diet (Persea americana) on sucrose-induced insulin resistance in Wistar rats. J. Food Drug Anal. 24, 350-357, doi:10.1016/j.jfda.2015.11.005
    OpenUrlCrossRef
  19. ↵
    1. Devan, S. R. K.,
    2. Arumugam, S.,
    3. Shankar, G. and
    4. Poosala, S.
    (2018). Differential sensitivity of chronic high-fat-diet-induced obesity in Sprague-Dawley rats. J. Basic Clin. Physiol. Pharmacol., doi:10.1515/jbcpp-2017-0030
    OpenUrlCrossRef
  20. ↵
    1. DiMeglio, D. P. and
    2. Mattes, R. D.
    (2000). Liquid versus solid carbohydrate: effects on food intake and body weight. Int. J. Obes. 24, 794-800. doi:10.1038/sj.ijo.0801229
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    1. DiNicolantonio, J. J.,
    2. O'Keefe, J. H. and
    3. Lucan, S. C.
    (2015). Added fructose: a principal driver of type 2 diabetes mellitus and its consequences. Mayo Clin. Proc. 90, 372-381, doi:10.1016/j.mayocp.2014.12.019
    OpenUrlCrossRefPubMed
  22. ↵
    1. Dutta, K.,
    2. Podolin, D. A.,
    3. Davidson, M. B. and
    4. Davidoff, A. J.
    (2001). Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance. Diabetes 50, 1186-1192, doi:10.2337/diabetes.50.5.1186
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Ecker, A.,
    2. Gonzaga, T.,
    3. Seeger, R. L.,
    4. Santos, M. M. D.,
    5. Loreto, J. S.,
    6. Boligon, A. A.,
    7. Meinerz, D. F.,
    8. Lugokenski, T. H.,
    9. Rocha, J. and
    10. Barbosa, N. V.
    (2017). High-sucrose diet induces diabetic-like phenotypes and oxidative stress in Drosophila melanogaster: protective role of Syzygium cumini and Bauhinia forficata. Biomed. Pharmacother. 89, 605-616, doi:10.1016/j.biopha.2017.02.076
    OpenUrlCrossRef
  24. ↵
    1. El Hafidi, M.,
    2. Cuellar, A.,
    3. Ramirez, J. and
    4. Banos, G.
    (2001). Effect of sucrose addition to drinking water, that induces hypertension in the rats, on liver microsomal Δ9 and Δ5-desaturase activities. J. Nutr. Biochem. 12, 396-403. doi:10.1016/S0955-2863(01)00154-1
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    1. Engin, A.
    (2017). The definition and prevalence of obesity and metabolic syndrome. Adv. Exp. Med. Biol. 960, 1-17, doi:10.1007/978-3-319-48382-5_1. doi:10.1007/978-3-319-48382-5
    OpenUrlCrossRefPubMed
  26. ↵
    1. Gregersen, S.,
    2. Samocha-Bonet, D.,
    3. Heilbronn, L. K. and
    4. Campbell, L. V.
    (2012). Inflammatory and oxidative stress responses to high-carbohydrate and high-fat meals in healthy humans. J. Nutr. Metab. 2012, 238056, doi:10.1155/2012/238056
    OpenUrlCrossRefPubMed
  27. ↵
    1. Hissin, P. J. and
    2. Hilf, R.
    (1976). A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74, 214-226. doi:10.1016/0003-2697(76)90326-2
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    1. Jensen, T.,
    2. Abdelmalek, M. F.,
    3. Sullivan, S.,
    4. Nadeau, K. J.,
    5. Green, M.,
    6. Roncal, C.,
    7. Nakagawa, T.,
    8. Kuwabara, M.,
    9. Sato, Y.,
    10. Kang, D. H. et al.
    (2018). Fructose and sugar: a major mediator of non-alcoholic fatty liver disease. J. Hepatol. 68, 1063-1075, doi:10.1016/j.jhep.2018.01.019
    OpenUrlCrossRefPubMed
  29. ↵
    1. Jimoh, A.,
    2. Tanko, Y.,
    3. Ahmed, A.,
    4. Mohammed, A. and
    5. Ayo, J. O.
    (2018). Resveratrol prevents high-fat diet-induced obesity and oxidative stress in rabbits. Pathophysiology, doi:10.1016/j.pathophys.2018.07.003
    OpenUrlCrossRef
  30. ↵
    1. Kaswala, D. H.,
    2. Lai, M. and
    3. Afdhal, N. H.
    (2016). Fibrosis assessment in nonalcoholic fatty liver disease (NAFLD) in 2016. Dig. Dis. Sci. 61, 1356-1364, doi:10.1007/s10620-016-4079-4
    OpenUrlCrossRef
  31. ↵
    1. Kawasaki, T.,
    2. Kashiwabara, A.,
    3. Sakai, T.,
    4. Igarashi, K.,
    5. Ogata, N.,
    6. Watanabe, H.,
    7. Ichiyanagi, K. and
    8. Yamanouchi, T.
    (2005). Long-term sucrose-drinking causes increased body weight and glucose intolerance in normal male rats. Br. J. Nutr. 93, 613-618. doi:10.1079/BJN20051407
    OpenUrlCrossRefPubMed
  32. ↵
    1. Kleiner, D. E.,
    2. Brunt, E. M.,
    3. Van Natta, M.,
    4. Behling, C.,
    5. Contos, M. J.,
    6. Cummings, O. W.,
    7. Ferrell, L. D.,
    8. Liu, Y. C.,
    9. Torbenson, M. S.,
    10. Unalp-Arida, A. et al.
    (2005). Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313-1321, doi:10.1002/hep.20701
    OpenUrlCrossRefPubMedWeb of Science
  33. ↵
    1. Kosuru, R. and
    2. Singh, S.
    (2017). Pterostilbene ameliorates insulin sensitivity, glycemic control and oxidative stress in fructose-fed diabetic rats. Life Sci. 182, 112-121, doi:10.1016/j.lfs.2017.06.015
    OpenUrlCrossRef
  34. ↵
    1. Lee, J. W.,
    2. Lim, N. K. and
    3. Park, H. Y.
    (2018). The product of fasting plasma glucose and triglycerides improves risk prediction of type 2 diabetes in middle-aged Koreans. BMC Endocr. Disord. 18, 33, doi:10.1186/s12902-018-0259-x
    OpenUrlCrossRef
  35. ↵
    1. Levine, R. L.,
    2. Garland, D.,
    3. Oliver, C. N.,
    4. Amici, A.,
    5. Climent, I.,
    6. Lenz, A. G.,
    7. Ahn, B. W.,
    8. Shaltiel, S. and
    9. Stadtman, E. R.
    (1990). Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186, 464-478. doi:10.1016/0076-6879(90)86141-H
    OpenUrlCrossRefPubMedWeb of Science
  36. ↵
    1. Li, X.,
    2. Wang, X. and
    3. Gao, P.
    (2017). Diabetes mellitus and risk of hepatocellular carcinoma. Biomed Res. Int. 2017, 5202684, doi:10.1155/2017/5202684
    OpenUrlCrossRef
  37. ↵
    1. Lim, J. S.,
    2. Mietus-Snyder, M.,
    3. Valente, A.,
    4. Schwarz, J. M. and
    5. Lustig, R. H.
    (2010). The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat. Rev. Gastroenterol. Hepatol. 7, 251-264, doi:10.1038/nrgastro.2010.41
    OpenUrlCrossRefPubMed
  38. ↵
    1. Lima, M. L.,
    2. Leite, L. H.,
    3. Gioda, C. R.,
    4. Leme, F. O.,
    5. Couto, C. A.,
    6. Coimbra, C. C.,
    7. Leite, V. H. and
    8. Ferrari, T. C.
    (2016). A novel Wistar rat model of obesity-related nonalcoholic fatty liver disease induced by sucrose-rich diet. J. Diabetes Res. 2016, 9127076, doi:10.1155/2016/9127076
    OpenUrlCrossRef
  39. ↵
    1. Lustig, R. H.,
    2. Schmidt, L. A. and
    3. Brindis, C. D.
    (2012). Public health: the toxic truth about sugar. Nature 482, 27-29, doi:10.1038/482027a
    OpenUrlCrossRefPubMedWeb of Science
  40. ↵
    1. Malafaia, A. B.,
    2. Nassif, P. A.,
    3. Ribas, C. A.,
    4. Ariede, B. L.,
    5. Sue, K. N. and
    6. Cruz, M. A.
    (2013). Obesity induction with high fat sucrose in rats. Arq. Bras. Cir. Dig. 26, Suppl 1, 17-21. doi:10.1590/S0102-67202013000600005
    OpenUrlCrossRef
  41. ↵
    1. Malik, V. S.,
    2. Popkin, B. M.,
    3. Bray, G. A.,
    4. Despres, J. P.,
    5. Willett, W. C. and
    6. Hu, F. B.
    (2010). Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta- analysis. Diabetes Care 33, 2477-2483, doi:10.2337/dc10-1079
    OpenUrlAbstract/FREE Full Text
  42. ↵
    1. Marklund, S. and
    2. Marklund, G.
    (1974). Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47, 469-474. doi:10.1111/j.1432-1033.1974.tb03714.x
    OpenUrlCrossRefPubMedWeb of Science
  43. ↵
    1. Masek, T.,
    2. Filipovic, N.,
    3. Vuica, A. and
    4. Starcevic, K.
    (2017). Effects of treatment with sucrose in drinking water on liver histology, lipogenesis and lipogenic gene expression in rats fed high-fiber diet. Prostaglandins Leukot. Essent Fatty Acids 116, 1-8, doi:10.1016/j.plefa.2016.11.001
    OpenUrlCrossRef
  44. ↵
    1. Matsuda, M. and
    2. DeFronzo, R. A.
    (1999). Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462-1470, doi:10.2337/diacare.22.9.1462
    OpenUrlAbstract/FREE Full Text
  45. ↵
    1. Monteillet, L.,
    2. Gjorgjieva, M.,
    3. Silva, M.,
    4. Verzieux, V.,
    5. Imikirene, L.,
    6. Duchampt, A.,
    7. Guillou, H.,
    8. Mithieux, G. and
    9. Rajas, F.
    (2018). Intracellular lipids are an independent cause of liver injury and chronic kidney disease in nonalcoholic fatty liver disease-like context. Mol. Metab., doi:10.1016/j.molmet.2018.07.006
    OpenUrlCrossRef
  46. ↵
    1. Nakagawa, T.,
    2. Hu, H.,
    3. Zharikov, S.,
    4. Tuttle, K. R.,
    5. Short, R. A.,
    6. Glushakova, O.,
    7. Ouyang, X.,
    8. Feig, D. I.,
    9. Block, E. R.,
    10. Herrera-Acosta, J. et al.
    (2006). A causal role for uric acid in fructose- induced metabolic syndrome. Am. J. Physiol. Renal. Physiol. 290, F625-F631, doi:10.1152/ajprenal.00140.2005
    OpenUrlCrossRefPubMedWeb of Science
  47. ↵
    1. Nayak, N. C.,
    2. Sathar, S. A.,
    3. Mughal, S.,
    4. Duttagupta, S.,
    5. Mathur, M. and
    6. Chopra, P.
    (1996). The nature and significance of liver cell vacuolation following hepatocellular injury – an analysis based on observations on rats rendered tolerant to hepatotoxic damage. Virchows Arch. 428, 353-365. doi:10.1007/BF00202202
    OpenUrlCrossRefPubMed
  48. ↵
    1. Oliveira Crege, D. R. X.,
    2. Miotto, A. M.,
    3. Borghi, F.,
    4. Wolf-Nunes, V. and
    5. Kassisse, D. M. G.
    (2016). Cardiometabolic alterations in Wistar rats on a six-week hyperlipidic, hypercholesterolemic diet. Int. J. Cardiovasc. Sci. 29, 362-369, doi:10.5935/2359-4802.20160056
    OpenUrlCrossRef
  49. ↵
    1. Pan, A. and
    2. Hu, F. B.
    (2011). Effects of carbohydrates on satiety: differences between liquid and solid food. Curr. Opin. Clin. Nutr. Metab. Care 14, 385-390, doi:10.1097/MCO.0b013e328346df36
    OpenUrlCrossRefPubMed
  50. ↵
    1. Pan, D. A.,
    2. Lillioja, S.,
    3. Kriketos, A. D.,
    4. Milner, M. R.,
    5. Baur, L. A.,
    6. Bogardus, C.,
    7. Jenkins, A. B. and
    8. Storlien, L. H.
    (1997). Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46, 983-988, doi:10.2337/diab.46.6.983
    OpenUrlAbstract/FREE Full Text
  51. ↵
    1. Paradis, V.,
    2. Perlemuter, G.,
    3. Bonvoust, F.,
    4. Dargere, D.,
    5. Parfait, B.,
    6. Vidaud, M.,
    7. Conti, M.,
    8. Huet, S.,
    9. Ba, N.,
    10. Buffet, C. et al.
    (2001). High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology 34, 738-744, doi:10.1053/jhep.2001.28055
    OpenUrlCrossRefPubMedWeb of Science
  52. ↵
    1. Pinafo, M. S.,
    2. Benedetti, P. R.,
    3. Gaiotte, L. B.,
    4. Costa, F. G.,
    5. Schoffen, J. P. F.,
    6. Fernandes, G. S. A.,
    7. Chuffa, L. G. A. and
    8. Seiva, F. R. F.
    (2019). Effects of Bauhinia forficata on glycemia, lipid profile, hepatic glycogen content and oxidative stress in rats exposed to Bisphenol A. Toxicol. Rep. 6, 244-252, doi:10.1016/j.toxrep.2019.03.001
    OpenUrlCrossRef
  53. ↵
    1. Rahman, M. M.,
    2. Alam, M. N.,
    3. Ulla, A.,
    4. Sumi, F. A.,
    5. Subhan, N.,
    6. Khan, T.,
    7. Sikder, B.,
    8. Hossain, H.,
    9. Reza, H. M. and
    10. Alam, M. A.
    (2017). Cardamom powder supplementation prevents obesity, improves glucose intolerance, inflammation and oxidative stress in liver of high carbohydrate high fat diet induced obese rats. Lipids Health Dis. 16, 151, doi:10.1186/s12944-017-0539-x
    OpenUrlCrossRef
  54. ↵
    1. Rodrigues, A. H.,
    2. Moreira, C. C.,
    3. Mario, E. G.,
    4. de Souza Cordeiro, L. M.,
    5. Avelar, G. F.,
    6. Botion, L. M. and
    7. Chaves, V. E.
    (2016). Differential modulation of cytosolic lipases activities in liver and adipose tissue by high-carbohydrate diets. Endocrine 53, 423-432, doi:10.1007/s12020-016-0886-9
    OpenUrlCrossRef
  55. ↵
    1. Roe, J. H. and
    2. Dailey, R. E.
    (1966). Determination of glycogen with the anthrone reagent. Anal. Biochem. 15, 245-250. doi:10.1016/0003-2697(66)90028-5
    OpenUrlCrossRefPubMedWeb of Science
  56. ↵
    1. Sa-Nakanishi, A. B.,
    2. Soni-Neto, J.,
    3. Moreira, L. S.,
    4. Goncalves, G. A.,
    5. Silva, F. M. S.,
    6. Bracht, L.,
    7. Bersani-Amado, C. A.,
    8. Peralta, R. M.,
    9. Bracht, A. and
    10. Comar, J. F.
    (2018). Anti-inflammatory and antioxidant actions of methyl jasmonate are associated with metabolic modifications in the liver of arthritic rats. Oxid. Med. Cell Longev. 2018, 2056250, doi:10.1155/2018/2056250
    OpenUrlCrossRef
  57. ↵
    1. Sanders, F. W. and
    2. Griffin, J. L.
    (2016). De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose. Biol. Rev. Camb. Philos. Soc. 91, 452-468, doi:10.1111/brv.12178
    OpenUrlCrossRefPubMed
  58. ↵
    1. Seiva, F. R.,
    2. Chuffa, L. G.,
    3. Ebaid, G. M.,
    4. Silva, T.,
    5. Fernandes, A. A. and
    6. Novelli, E. L.
    (2011). Calorimetry, morphometry, oxidative stress, and cardiac metabolic response to growth hormone treatment in obese and aged rats. Horm. Metab. Res. 43, 397-403, doi:10.1055/s-0031-1273769
    OpenUrlCrossRefPubMed
  59. ↵
    1. Seiva, F. R.,
    2. Chuffa, L. G.,
    3. Braga, C. P.,
    4. Amorim, J. P. and
    5. Fernandes, A. A.
    (2012). Quercetin ameliorates glucose and lipid metabolism and improves antioxidant status in postnatally monosodium glutamate-induced metabolic alterations. Food Chem. Toxicol. 50, 3556-3561, doi:10.1016/j.fct.2012.07.009
    OpenUrlCrossRefPubMed
  60. ↵
    1. Simopoulos, A. P.
    (2013). Dietary omega-3 fatty acid deficiency and high fructose intake in the development of metabolic syndrome, brain metabolic abnormalities, and non-alcoholic fatty liver disease. Nutrients 5, 2901-2923, doi:10.3390/nu5082901
    OpenUrlCrossRef
  61. ↵
    1. Skolnik, N. S. and
    2. Ryan, D. H.
    (2014). Pathophysiology, epidemiology, and assessment of obesity in adults. J. Fam. Pract. 63, S3-S10.
    OpenUrl
  62. ↵
    1. Sousa, R. M. L.,
    2. Ribeiro, N. L. X.,
    3. Pinto, B. A. S.,
    4. Sanches, J. R.,
    5. da Silva, M. U.,
    6. Coelho, C. F. F.,
    7. Franca, L. M.,
    8. de Figueiredo Neto, J. A. and
    9. Paes, A. M. A.
    (2018). Long-term high- protein diet intake reverts weight gain and attenuates metabolic dysfunction on high-sucrose- fed adult rats. Nutr. Metab. (Lond) 15, 53, doi:10.1186/s12986-018-0290-y
    OpenUrlCrossRef
  63. ↵
    1. Stenvinkel, P.
    (2015). Obesity – a disease with many aetiologies disguised in the same oversized phenotype: has the overeating theory failed? Nephrol. Dial. Transplant. 30, 1656-1664, doi:10.1093/ndt/gfu338
    OpenUrlCrossRefPubMed
  64. ↵
    1. Stull, A. J.,
    2. Apolzan, J. W.,
    3. Thalacker-Mercer, A. E.,
    4. Iglay, H. B. and
    5. Campbell, W. W.
    (2008). Liquid and solid meal replacement products differentially affect postprandial appetite and food intake in older adults. J. Am. Diet Assoc. 108, 1226-1230, doi:10.1016/j.jada.2008.04.014
    OpenUrlCrossRefPubMed
  65. ↵
    1. Sun, S.,
    2. Hanzawa, F.,
    3. Umeki, M.,
    4. Ikeda, S.,
    5. Mochizuki, S. and
    6. Oda, H.
    (2018). Time- restricted feeding suppresses excess sucrose-induced plasma and liver lipid accumulation in rats. PLoS One 13, e0201261, doi:10.1371/journal.pone.0201261
    OpenUrlCrossRefPubMed
  66. ↵
    1. Tilg, H. and
    2. Moschen, A. R.
    (2010). Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52, 1836-1846, doi:10.1002/hep.24001
    OpenUrlCrossRefPubMedWeb of Science
  67. ↵
    1. Unger, R. H. and
    2. Scherer, P. E.
    (2010). Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity. Trends Endocrinol. Metab. 21, 345-352, doi:10.1016/j.tem.2010.01.009
    OpenUrlCrossRefPubMedWeb of Science
  68. ↵
    1. Vijayakumar, A.,
    2. Aryal, P.,
    3. Wen, J.,
    4. Syed, I.,
    5. Vazirani, R. P.,
    6. Moraes-Vieira, P. M.,
    7. Camporez, J. P.,
    8. Gallop, M. R.,
    9. Perry, R. J.,
    10. Peroni, O. D. et al.
    (2017). Absence of carbohydrate responsE element binding protein in adipocytes causes systemic insulin resistance and impairs glucose transport. Cell Rep. 21, 1021-1035, doi:10.1016/j.celrep.2017.09.091
    OpenUrlCrossRef
  69. ↵
    1. Wan, W.,
    2. Jiang, B.,
    3. Sun, L.,
    4. Xu, L. and
    5. Xiao, P.
    (2017). Metabolomics reveals that vine tea (Ampelopsis grossedentata) prevents high-fat-diet-induced metabolism disorder by improving glucose homeostasis in rats. PLoS One 12, e0182830, doi:10.1371/journal.pone.0182830
    OpenUrlCrossRef
  70. ↵
    1. Wang, J. H.,
    2. Bose, S.,
    3. Lim, S. K.,
    4. Ansari, A.,
    5. Chin, Y. W.,
    6. Choi, H. S. and
    7. Kim, H.
    (2017). Houttuynia cordata facilitates metformin on ameliorating insulin resistance associated with gut microbiota alteration in OLETF rats. Genes (Basel) 8, doi:10.3390/genes8100239
    OpenUrlCrossRef
  71. ↵
    1. Wong, S. K.,
    2. Chin, K. Y.,
    3. Suhaimi, F. H.,
    4. Fairus, A. and
    5. Ima-Nirwana, S.
    (2016). Animal models of metabolic syndrome: a review. Nutr. Metab. (Lond) 13, 65, doi:10.1186/s12986-016-0123-9
    OpenUrlCrossRef
  72. ↵
    1. Xu, Y.,
    2. Han, J.,
    3. Dong, J.,
    4. Fan, X.,
    5. Cai, Y.,
    6. Li, J.,
    7. Wang, T.,
    8. Zhou, J. and
    9. Shang, J.
    (2019). Metabolomics characterizes the effects and mechanisms of Quercetin in nonalcoholic fatty liver disease development. Int. J. Mol. Sci. 20, doi:10.3390/ijms20051220
    OpenUrlCrossRef
  73. ↵
    1. Zatroch, K. K.,
    2. Knight, C. G.,
    3. Reimer, J. N. and
    4. Pang, D. S.
    (2017). Refinement of intraperitoneal injection of sodium pentobarbital for euthanasia in laboratory rats (Rattus norvegicus). BMC Vet. Res. 13, 60, doi:10.1186/s12917-017-0982-y
    OpenUrlCrossRefPubMed
  74. ↵
    1. Zhang, L.,
    2. Wu, X.,
    3. Liao, S.,
    4. Li, Y.,
    5. Zhang, Z.,
    6. Chang, Q.,
    7. Xiao, R. and
    8. Liang, B.
    (2016). Tree shrew (Tupaia belangeri chinensis), a novel non-obese animal model of non-alcoholic fatty liver disease. Biol. Open 5, 1545-1552, doi:10.1242/bio.020875
    OpenUrlAbstract/FREE Full Text
View Abstract
Back to top

RSSRSS

Keywords

 Download PDF

Email
Research Article
Long-term sucrose solution consumption causes metabolic alterations and affects hepatic oxidative stress in Wistar rats
Ellen Mayara Souza Cruz, Juliana Maria Bitencourt de Morais, Carlos Vinícius Dalto da Rosa, Mellina da Silva Simões, Jurandir Fernando Comar, Luiz Gustavo de Almeida Chuffa, Fábio Rodrigues Ferreira Seiva
Biology Open 2020 9: bio047282 doi: 10.1242/bio.047282 Published 28 February 2020
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Alerts

Article Navigation

Other journals from The Company of Biologists

Advertisement

Biology Open and COVID-19

We are aware that the COVID-19 pandemic is having an unprecedented impact on researchers worldwide. The Editors of all The Company of Biologists’ journals have been considering ways in which we can alleviate concerns that members of our community may have around publishing activities during this time. Read about the actions we are taking at this time.

Please don’t hesitate to contact the Editorial Office if you have any questions or concerns.

2020 at The Company of Biologists

Despite 2020’s challenges, we achieved a lot at The Company of Biologists. In the midst of the pandemic, we have seen long-term projects and new ventures come to fruition. Read our full lowdown of 2020.

Interview- Sebastian Markert

Sebastian Markert is first author of a paper in BiO using C. elegans to model amyotrophic lateral sclerosis. In an interview, he talks about the potential implications of his work and his future plans.

Three communities to support biologists to everywhere

Online communities have never been more important. If you’re looking for somewhere to meet fellow scientists, take part in topical discussions and find virtual events in your field, take a look at each of our community sites:

  • The Node: the community site for and by developmental biologists
  • preLights: the preprint highlights service run by the biological community
  • FocalPlane: the community site for microscopists and biologists alike